DELTA CORP LTD (NSE:DELTACORP) Q3 FY22 Earnings Concall dated Jan. 12, 2022 Corporate Participants: Hardik Dhebar -- Group Chief Financial Officer Analysts:
DELTA CORP LTD (DELTACORP) Q3 FY22 Earnings Concall Transcript
Categories
Health Care
IPO Alert: Hexagon Nutrition files papers to raise funds through IPO
The clinical nutrition sector, often referred to as the health and wellness sector, has a huge market in India. It comprises medical
Infographic: All you need to know about Dr Reddy’s Labs Q2 performance
Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with a growth
Infographic: How Cipla performed in Q2 2022
Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of ₹5,580 crores with a growth of 9% year
IPO Alert: API Holdings files DRHP with SEBI for public issue
Healthcare spending in India grew at a healthy compound annual rate of 13% from 2015 to 2019 and reached around ₹9.6 trillion.
IOL Chemicals and Pharmaceuticals Ltd (IOLCP) Q2 FY22 Earnings Concall Transcript
IOL Chemicals and Pharmaceuticals LTd (NSE:IOLCP) Q2 FY22 Earnings Concall dated Nov. 16, 2021 Corporate Participants: Monish Shah -- Vice President, Research Sanjay
Krishna Institute of Medical Sciences Ltd (KIMS) Q2 FY22 Earnings Concall Transcript
Krishna Institute of Medical Sciences Ltd (NSE:KIMS) Q2 FY22 Earnings Concall dated Nov. 11, 2021, Corporate Participants: B. Bhaskar Rao — Managing
Earnings: Aurobindo Pharma results in Q2 2022
Aurobindo Pharma (NSE: AUROPHARMA) reported its second-quarter 2022 earnings results today. The company had a consolidated net profit of ₹696.71 crores with
Divi’s Laboratories Ltd (DIVISLAB) Q2 FY22 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE:DIVISLAB) Q2 FY22 Earnings Concall dated Nov. 06, 2021. Corporate Participants: M. Satish Choudhury -- Company Secretary & Compliance Officer
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY22 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY22 Earnings Call dated Nov. 02, 2021 Corporate Participants: Nimish Desai -- Head-Investor Relations Dilip Shanghvi --
Key highlights from Sun Pharma Q2 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion with a
Cipla Ltd (CIPLA) Q2 FY22 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q2 FY22 Earnings Concall dated Oct. 26, 2021 Corporate Participants: Naveen Bansal -- Director, Finance Kedar Upadhye -- Global
Key highlights from Dr Reddy’s Q2 2022 earnings results
Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had total revenue
How Cipla performed in Q2 2022
The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue increased by
IPO Alert: Wellness Forever Medicare files papers for a public listing
The Indian pharmaceutical industry is the world’s third-largest by volume and 14th largest by value. The turnover of the country’s pharmaceutical market
ICICI Prudential Life Insurance Co Ltd (ICICIPRULI) Q2 FY22 Earnings Concall Transcript
ICICI Prudential Life Insurance Co Ltd (NSE:ICICIPRULI) Q2 FY22 Earnings Concall dated Oct. 19, 2021 Corporate Participants: N. S. Kannan -- Managing
IPO Alert: Medanta hospital chain files papers for public listing
The hospital industry in India is forecasted to grow to ₹8.6 trillion by 2022 from ₹4 trillion in 2017, at a CAGR
IPO Alert: Sahajanand Medical Technologies is all set to go public
The global peripheral intervention market is projected to grow from $3.26 billion in 2020 to $5.89 billion in 2026, at a CAGR
DELTA CORP LTD (DELTACORP) Q2 FY22 Earnings Call Transcript
DELTA CORP LTD (NSE: DELTACORP) Q2 FY22 earnings call dated Oct. 12, 2021. Corporate Participants: Alpesh Thakkar -- Investor Relations Hardik Dhebar --
IPO Alert: Healthium Medtech files draft papers as it looks to raise funds
Healthcare is amongst the fastest-growing sectors in India, both in terms of revenue and employment. The Indian healthcare industry is expected to
IPO Alert: What to expect when Emcure Pharma hits public markets
India's domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024 and further